학술논문

A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer
Document Type
Article
Source
In: Oncologist. (Oncologist, December 2023, 28(12):e1248-e1258)
Subject
Language
English
ISSN
1549490X
10837159